ImmuCell publishes update to financial calendar
ICCC•ImmuCell expects to report unaudited results for the quarter ended Sept. 30, 2026, and file its Form 10-Q on Nov. 12 after the market close. A conference call is scheduled for Nov. 13 at 9 a.m. ET; no changes are anticipated to preliminary quarterly sales disclosed Oct. 12.
1. Results and call dates
ImmuCell expects to report unaudited results for the quarter ended Sept. 30, 2026, and file its Form 10-Q on Nov. 12, 2026, following the market close. A conference call and webcast to review the results are scheduled for Nov. 13 at 9 a.m. ET, with a replay available through Nov. 20.
2. Preliminary sales
The company anticipates no changes to preliminary quarterly sales results disclosed Oct. 12, 2026.
